Paul Greene

7.9k total citations · 1 hit paper
61 papers, 5.1k citations indexed

About

Paul Greene is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Paul Greene has authored 61 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 26 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Paul Greene's work include Neurological disorders and treatments (39 papers), Botulinum Toxin and Related Neurological Disorders (21 papers) and Parkinson's Disease Mechanisms and Treatments (19 papers). Paul Greene is often cited by papers focused on Neurological disorders and treatments (39 papers), Botulinum Toxin and Related Neurological Disorders (21 papers) and Parkinson's Disease Mechanisms and Treatments (19 papers). Paul Greene collaborates with scholars based in United States, Canada and Germany. Paul Greene's co-authors include Stanley Fahn, Curt R. Freed, David Eidelberg, Robert E. Breeze, Sandra Dillon, Wei‐Yann Tsai, John Q. Trojanowski, Howard N. Winfield, Richard Kao and William DuMouchel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Neurology.

In The Last Decade

Paul Greene

60 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease

2001 1.7k citations Curt R. Freed, Paul Greene et al. profile →

Peers

Paul Greene

NEURO

CMN

MB

CN

PHYSI

G. V. Sawle United Kingdom

Pierre Césaro France

Hyder A. Jinnah United States

Åke Seiger Sweden

Anne Rosser United Kingdom

Emmanuel Roze France

Imaharu Nakano Japan

Andrew Feigin United States

F.G.I. Jennekens Netherlands

Pietro Tonali Italy

G. V. Sawle United Kingdom

Paul Greene

3.5k ×1.2

NEURO

3.2k ×1.3

CMN

1.3k ×1.0

MB

895 ×1.4

CN

332 ×0.5

PHYSI

Citations per year, relative to Paul Greene Paul Greene (= 1×) peers G. V. Sawle

Countries citing papers authored by Paul Greene

Since Specialization

Citations

This map shows the geographic impact of Paul Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Greene more than expected).

Fields of papers citing papers by Paul Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Greene. The network helps show where Paul Greene may publish in the future.

Co-authorship network of co-authors of Paul Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Greene. A scholar is included among the top collaborators of Paul Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Greene. Paul Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Xie, Tao, et al.. (2015). Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. npj Parkinson s Disease. 1(1). 15007–15007. 34 indexed citations

2.

Greene, Paul, et al.. (2010). Myopathy and parkinsonism in phosphoglycerate kinase deficiency. Muscle & Nerve. 41(5). 707–710. 41 indexed citations

3.

Ma, Yilong, Chengke Tang, Thomas Chaly, et al.. (2009). Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and ¹⁸F-FDOPA PET Outcomes. Journal of Nuclear Medicine. 51(1). 7–15. 140 indexed citations

4.

Goldman, Sylvie, Cuiling Wang, Miran Salgado, et al.. (2008). Motor stereotypies in children with autism and other developmental disorders. Developmental Medicine & Child Neurology. 51(1). 30–38. 187 indexed citations

5.

Saunders‐Pullman, Rachel, Deborah Raymond, Geetha Senthil, et al.. (2007). Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish–Mennonites. American Journal of Medical Genetics Part A. 143A(18). 2098–2105. 48 indexed citations

6.

Davidzon, Guido, Paul Greene, Michelangelo Mancuso, et al.. (2006). Early‐onset familial parkinsonism due to POLG mutations. Annals of Neurology. 59(5). 859–862. 177 indexed citations

7.

Gilbert, Gordon, Qiping Yu, Clifford Qualls, et al.. (2004). Reaction Time and Movement Time After Embryonic Cell Implantation in Parkinson Disease. Archives of Neurology. 61(6). 858–858. 21 indexed citations

8.

Gilbert, Gordon, Clifton L. Gooch, & Paul Greene. (2002). Extensor digitorum brevis test and resistance to botulinum toxin type A. Muscle & Nerve. 26(6). 828–831. 16 indexed citations

9.

Greene, Paul, Susan Bressman, Blair Ford, & Keith Hyland. (2000). Parkinsonism, dystonia, and hemiatrophy. Movement Disorders. 15(3). 537–541. 12 indexed citations

10.

Nygaard, Torbjoern G., Deborah Raymond, Caiping Chen, et al.. (1999). Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Annals of Neurology. 46(5). 794–798. 71 indexed citations

11.

Grieger, Ingrid & Paul Greene. (1998). The Psychological Autopsy as a Tool in Student Affairs.. Journal of college student development. 39(4). 388–392. 5 indexed citations

12.

Ford, Blair, Elan D. Louis, Paul Greene, & Stanley Fahn. (1996). Oral and genital pain syndromes in Parkinson's disease. Movement Disorders. 11(4). 421–426. 69 indexed citations

13.

Greene, Paul & Stanley Fahn. (1996). Response to botulinum toxin F in seronegative botulinum toxin A—resistant patients. Movement Disorders. 11(2). 181–184. 41 indexed citations

14.

Lang, Anthony E., et al.. (1994). Case 1, 1994: Rapidly progressive aphasia, apraxia, dementia, myoclonus, and parkinsonism. Movement Disorders. 9(3). 358–366. 11 indexed citations

15.

Greene, Paul, Stanley Fahn, & Beverly Diamond. (1994). Development of resistance to botulinum toxin type A in patients with torticollis. Movement Disorders. 9(2). 213–217. 304 indexed citations

16.

Greene, Paul & Stanley Fahn. (1993). Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Movement Disorders. 8(4). 479–483. 74 indexed citations

17.

Greene, Paul & Stanley Fahn. (1992). Baclofen in the treatment of idiopathic dystonia in children. Movement Disorders. 7(1). 48–52. 49 indexed citations

18.

Greene, Paul, et al.. (1990). Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct. Movement Disorders. 5(3). 235–238. 40 indexed citations

19.

Greene, Paul, Heidi Shale, & Stanley Fahn. (1988). Analysis of open‐label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Movement Disorders. 3(1). 46–60. 113 indexed citations

20.

Brin, Mitchell F., Stanley Fahn, Carol Moskowitz, et al.. (1987). Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Movement Disorders. 2(4). 237–254. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact